IDiyas

For the Inventor, By the Inventor

Springfield, NJ, United States of America

Tao Wang

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 8.3

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Sprinfield, NJ (US) (2009)
  • Springfield, NJ (US) (2009 - 2013)
  • Berkeley Heights, NJ (US) (2016 - 2018)
  • Cranford, NJ (US) (2023)

Company Filing History:

goldMedal10 out of 1,829 
 
Schering Corporation
 patents
silverMedal4 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal1 out of 2 
 
Werthenstein Biopharma Gmbh
 patents
where one patent can have more than one assignee

Years Active: 2009-2023

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 11827614 - Synthetic pathway to belzutifan and crystalline phases of synthetic intermediates (2023-11-28),
2. 9873707 - Methods and intermediates for preparing macrolactams (2018-01-23),
3. 9238604 - Process and intermediates for preparing macrolactams (2016-01-19),
4. 8618314 - Exo- and diastereo-selective synthesis of himbacine analogs (2013-12-31),
5. 8273790 - Exo-selective synthesis of himbacine analogs (2012-09-25),
6. 8258319 - Exo- and diastereo- selective synthesis of himbacine analogs (2012-09-04),
7. 8138180 - Exo-selective synthesis of himbacine analogs (2012-03-20),
8. 7989653 - Exo- and diastereo-selective syntheses of himbacine analogs (2011-08-02),
9. 7772276 - Exo-selective synthesis of himbacine analogs (2010-08-10),
10. 7678948 - Synthesis of 3-(5-nitrocyclohex-1-enyl) acrylic acid and esters thereof (2010-03-16),
11. 7626045 - Synthesis of himbacine analogs (2009-12-01),
12. 7605275 - Exo- and diastereo- selective syntheses of himbacine analogs (2009-10-20),
13. 7553987 - Synthesis of 3-(5-nitrocyclohex-1-enyl) acrylic acid and esters thereof (2009-06-30),
14. 7541471 - Synthesis of himbacine analogs (2009-06-02),

Title: The Inventor Profile: Tao Wang

Introduction:

Tao Wang, a renowned inventor based in Springfield, NJ (US), has made significant contributions to the field of pharmaceuticals with a notable portfolio of 14 patents. His innovative work focuses on enhancing treatments for cancer and viral infections.

Latest Patents:

1. Synthetic pathway to belzutifan and crystalline phases of synthetic intermediates: Wang's patent discloses crystalline forms of synthetic intermediates crucial for producing belzutifan, a potent HIF-2𝝰 inhibitor for cancer therapy.

2. Methods and intermediates for preparing macrolactams: This patent includes compounds that serve as key intermediates in the synthesis of macrolactams, with applications in inhibiting HCV NS3 protease for therapeutic and research purposes.

Career Highlights:

Tao Wang's expertise has been honed through employment at prestigious companies like Schering Corporation and Merck Sharp & Dohme Corporation. His innovative spirit and dedication to advancing pharmaceutical science have propelled him to the forefront of the industry.

Collaborations:

Throughout his career, Wang has collaborated with esteemed professionals such as Tiruvettipuram K Thiruvengadam and Jing Liao, enriching his projects with diverse perspectives and expertise. These collaborations have led to groundbreaking advancements in drug development and treatment modalities.

Conclusion:

In conclusion, Tao Wang's inventive prowess and commitment to improving healthcare through innovative pharmaceutical solutions have solidified his reputation as a leading inventor in the field. His patents and collaborations reflect a legacy of excellence that continues to inspire future generations in the realm of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…